

PAH Pathways offers a wealth of resources including one-on-one support from PAH Pathways counselors in your area.
Learn more »
PAH Pathways offers patients on Ventavis a clear path to getting started on therapy. Working with your doctor's office, PAH Pathways and your specialty pharmacy make it easier for you to get your medicine when you need it. Here's how it all comes together:

1. Your doctor prescribes Ventavis by completing enrollment forms: The process starts when your doctor's office faxes your Ventavis enrollment form to PAH Pathways.
2. PAH Pathways contacts you: Once we receive your Ventavis enrollment form, PAH Pathways will:
3. Specialty pharmacy coordinates your insurance coverage: Ventavis is not available in your retail pharmacy; rather, it is carried by a network of specialty pharmacies. Once your information has been sent to a specialty pharmacy, the pharmacy will:
4. You receive Ventavis and device training: Your specialty pharmacy ships Ventavis and the I-neb AAD System directly to your home. Your specialty pharmacy also schedules a training session for you so that you can understand how and when to take Ventavis. By using long and slow breaths, many patients have decreased their treatment times. A nurse educator conducts a training session, which can take place at your home or in a location that's convenient for you.
Know that if at any time you have a problem with your I-neb AAD System (for example, your I-neb AAD System is not working), you can call your specialty pharmacy's 24-hour emergency service number.
5. You receive ongoing support: Know that after you've started on therapy, you can contact PAH Pathways with questions or concerns about the delivery of your medicine, insurance coverage, or financial assistance programs if you are eligible.
You can also call PAH Pathways, Monday through Friday, 9 AM-8 PM (ET)/6 AM-5 PM (PT), with questions about any of these steps: 1-866-ACTELION (228-3546).
I-neb AAD is a registered trademark of Philips Respironics.
* Financial assistance programs are available for eligible patients.
Ventavis is indicated for the treatment of pulmonary arterial hypertension (WHO Group I) in patients with NYHA Class III or IV symptoms.
Important safety information about Ventavis
Because it lowers your blood pressure, Ventavis may cause dizziness, lightheadedness, and fainting. With Ventavis, the most common side effects are reddening of the face caused by dilation of blood vessels (flushing), increased cough, low blood pressure (hypotension), headaches, nausea, spasm of the jaw muscles that causes trouble opening your mouth, and fainting (syncope); other serious adverse events reported with the use of Ventavis include congestive heart failure, chest pain, supraventricular tachycardia, dyspnea, peripheral edema, and kidney failure. Before you start taking Ventavis, talk to your doctor to make sure you understand the side effects you might get.
Please see accompanying full Prescribing Information.
Tracleer
Please see accompanying full Prescribing Information, including BOXED WARNING and Medication Guide for Tracleer.